11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at 11 cheap small cap stocks to buy before the next breakout.
Arcutis Biotherapeutics Inc. (ARQT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 4,884,530 | $46,549,571 | +40% | 1.99% |
| 2. | Polar Capital Brian Ashford-Russell And Tim Woolley | 3,127,777 | $29,807,715 | -1% | 0.2% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,317,541 | $22,086,166 | +1% | 0.04% |
| 4. | OrbiMed Advisors Samuel Isaly | 1,914,479 | $18,244,985 | 0.33% | |
| 5. | Holocene Advisors Brandon Haley | 1,440,036 | $13,723,543 | -31% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | Large Shareholder | 8,684,232 | 2022-08-05 | Filing | |
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing | |
| $25.00 | 200,000 | Large Shareholder, Director | 4,267,564 | 2020-10-02 | Filing | |
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing | |
| $25.00 | 200,000 | Large Shareholder, Director | 4,267,564 | 2020-10-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.04 | 1,305 | Officer | 58,357 | 2023-08-21 | Filing | |
| $7.05 | 300 | Officer | 59,662 | 2023-08-21 | Filing | |
| $7.80 | 1,830 | Officer | 42,146 | 2023-05-31 | Filing | |
| $13.97 | 8,500 | Director | 165,825 | 2023-04-17 | Filing | |
| $12.01 | 8,500 | Director | 165,825 | 2023-04-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,212,786 | $87,797,848 | 0% | |
| 2. | 8,684,232 | $82,760,731 | 4.94% | |
| 3. | 5,226,009 | $49,803,866 | 0% | |
| 4. | 4,293,966 | $40,921,495 | 0.03% | |
| 5. | 4,231,374 | $40,324,995 | 0% |
News See All
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
5 Best Short Squeeze Stocks to Buy Now
There was a surge in hedge fund ownership of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) during the third quarter of 2022, as the number of smart money shareholders of the company nearly doubled.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Arcutis Biotherapeutics Q1 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. And welcome to Arcutis Biotherapeutics, Inc. Fourth Quarter 2022 Earnings Conference Call.
10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 small-cap stocks to buy according to billionaire Steve Cohen.
Is ARQT A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Arcutis Biotherapeutics, Inc. (ARQT) Going to Burn These Hedge Funds?
In this article you are going to find out whether hedge funds think Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is a good investment right now.
Billionaire Hedge Funds
